Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Home-Based Devices to Revolutionize the Lateral Flow Assays Market, The Market to Cross USD 11 Billion by 2028 - Arizton

      This image opens in the lightbox

      News provided by

      Arizton Advisory & Intelligence

      25 Jan, 2023, 20:00 GMT

      Share this article

      Share this article


      CHICAGO, Jan. 25, 2023 /PRNewswire/ -- According to Arizton's latest research report, the lateral flow assays market will grow at a CAGR of 3% from 2023-2028. Smartphone and AI integration in lateral flow immunoassay, evolving new applications of lateral flow assays, and a surge in demand for lateral flow assays in the food & beverage industry are the growing trends in the global lateral flow assays market. PocDoc, a Cambridge-based startup, received the CE mark approval for its digital reader powered with AI for lateral flow testing. A cloud-based system turns any smartphone or tablet into a universal digital reader, enabling healthcare organizations to perform large-scale lateral flow testing for any disease or marker. In February 2022, an AI-driven innovation that can read a COVID-19 lateral flow diagnostic test using a user's smartphone received special use approval from the MHRA.

      Continue Reading
      This image opens in the lightbox
      Lateral Flow Assays Market

      Lateral Flow Assays Market Report Scope

      Report Attributes

      Details

      Market Size (2028)

      USD 11.30 Billion

      Market Size (2022)

      USD 9.53 Billion

      CAGR (2022-2028)

      3 %

      Base Year

      2022

      Forecast Year

       

      2023-2028

      Market Segments

       

      Product, Application, Technique, End-Users, and Geography

      Geographic Analysis

       

      North America, Europe, APAC, Latin America, and Middle East & Africa

      Countries Covered

      The US, Canada, the UK, Germany, France, Italy, Russia, Spain, China, Japan, India, South Korea, Australia, Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and Turkey

      Page Number

      312

      Market Dynamics

      ·  Rising Prevalence of Chronic and Infectious Diseases

      ·  Growing Adoption of Home-Based Lateral Flow Assay Devices

      ·  Growing Demand for Point-Of-Care Testing

      Customization Request

      If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3682

      Click Here to Download the Free Sample Report

      The kits & reagents are expected to be the largest share of the global lateral flow assays market in 2022. These kits & reagents predominantly include biomarkers, assay kits, and reagents, including substrates, enzymes, specific proteins, lipids, and other test kits. The awareness of rapid and POC testing for various infectious diseases is one of the key factors driving the demand for rapid testing. The large market share of the segment is also attributed to the use of consumables reoccurring in nature, and the consumables segment generates continuous revenue for vendors. As a result, many renowned vendors are manufacturing consumables required for analyzers. This growth is attributable to the growing use of rapid tests in several points of care (POC) sites, such as emergency care, physician offices, ambulatory settings, nursing homes, and by individuals for diagnosing several diseases such as infectious diseases, diabetes, cancer, and other metabolic diseases.

      Growing Adoption of Home-Based Lateral Flow Assay Devices
      Home tests (also called self-tests or home tests) are typically sold over the counter and allow users to test self-collected samples and obtain results without the assistance of a trained medical professional. The home-use lateral flow assay device plays an important role in the treatment of cardiovascular disease and infectious diseases. These devices could also be very useful for testing pregnancy and stigmatized diseases such as HIV, allowing patients to perform self-tests at home. Therefore, the increasing incidence of these diseases and the growing adoption of lateral flow assay testing in home healthcare are expected to propel the lateral flow assays market growth. During COVID-19, many companies have introduced at-home lateral flow assays for COVID-19 testing. The fear of rushing to a diagnostic lab or hospital for testing has created a demand for at-home lateral flow assays. Some of the introduced tests for home use were:

      • In August 2020, BinaxNOW COVID-19 Ag Card and Panbio rapid COVID-19 test in September 2020
      • In September 2020, Roche launched the SARS-CoV-2 Rapid Antigen test.
      • Quidel launched during the COVID-19, Sofia 2 Flu+ SARS Antigen FIA
      • In June 2022, Siemens Healthineers launched the CLINITEST Rapid COVID-19 Antigen test and
      • BD has launched the BD Veritor SARS CoV-2 Test

      Vendor Landscape

      Abbott, Thermo Fisher Scientific, Siemen Healthineers, F. Hoffmann-la Roche, and Quidel are the major global players in the market. The market is highly consolidated, with key players accounting for major market shares. Moreover, the market also offers tremendous growth opportunities to vendors due to the pandemic. Therefore, vendors prioritize developing and commercializing a wide range of automated and advanced analyzers and rapid test kits and platforms, helping end-users.

      In March 2021, F. Hoffmann-La Roche launched the Cobas SARS-CoV-2 Set 1 variant test on their Cobas 6800/8800 systems. The company developed the test to detect and differentiate SARS-CoV-2 mutations in known variants. The company's innovative test helped researchers track mutation prevalence, measure the spread of circulating variants, and screen their latent impact on vaccines, treatments, and public health measures.

      Key Company Profiles

      • Abbott
      • F. Hoffmann-La Roche
      • Siemens Healthineers
      • Thermo Fisher Scientific
      • Quidel
      • BD
      • Abaxis
      • Abingdon Health
      • Access BIO
      • Arbor Vita
      • Assure Tech
      • Atomo Diagnostics
      • AccuBioTech
      • BIOMÉRIEUX
      • bioLytical Laboratories
      • BIO-RAD Laboratories
      • Biosynex
      • Cupid
      • DIALAB
      • HUMAN Gesellschaft für Biochemica und Diagnostica mbH
      • INTEC
      • J. Mitra & Co. Pvt. Ltd.
      • Meril Life Sciences
      • MP Biomedicals
      • Medsource Ozone Biomedicals
      • Nanjing Synthgene Medical Technology
      • OraSure Technologies
      • Premier Medical
      • QIAGEN
      • SD Biosensor
      • Rega Biotechnology
      • KHB
      • Türklab A.S.
      • Trinity Biotech
      • Wondfo
      • PerkinElmer
      • Merck KGaA

      Market Segmentation

      Product

      • Kits & Reagents
      • Readers

      Application

      • Clinical Diagnostics
      • Food Safety
      • Veterinary Diagnostics
      • Others

      Technique

      • Sandwich Assays
      • Competitive Assays

      End-Users

      • Hospitals & Clinics
      • Individuals
      • Diagnostic Laboratories
      • Food & Beverage Companies
      • Pharma & Biotech Companies
      • Others

      Geography

      • North America
        • US
        • Canada
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Russia
        • Spain
      • APAC
        • China
        • Japan
        • India
        • South Korea
        • Australia
        • Philippines
      • Latin America
        • Brazil
        • Mexico
        • Argentina
      • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • Turkey

      Click Here to Download the Free Sample Report

      Check Out Some of the Top-Selling Related Research Reports:

      Infectious Disease Diagnostics Market - Global Outlook and Forecast 2020-2025: The global infectious disease diagnostics market will reach USD 24 billion by 2025. Abbott, BD, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players and account for significant shares in the market.

      Hematology Diagnostics Market - Global Outlook & Forecast 2022-2027: The hematology diagnostics market is expected to reach USD 4,409.22 million by 2027. The analyzer automation has revolutionized hematology testing by reducing time and increasing the accuracy of the diagnosis. Along with the technological advancements, the regents used for the analyzers are also evolving with longer shelf life and overcoming the challenges in the market. 

      COVID-19 Rapid Antigen Test Kits Market - Global Outlook & Forecast 2022-2027: The COVID-19 rapid antigen tests market is expected to reach $743.07 million by 2027. Key players are engaging in strategic acquisitions as part of their inorganic growth strategy to improve sales and profit margins. Strategic M&As remains an important competitive strategy for key players to expand product offerings, access new technology, and increase rapid Covid-19 antigen test kits market share.

      COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026: The global COVID-19 diagnostics market is expected to reach USD 7.4 billion by 2026. The global coronavirus diagnostics market is highly dynamic, with several global, regional, and local company profiles offering a diverse range of analyzers, test kits, assays, and reagents to perform COVID-19 tests. Abbott, BD, Danaher, F. Hoffmann-La Roche, Siemens Healthineers, and Thermo Fisher Scientific are the major player in the diagnostics market.

      Table of Content

      1 RESEARCH METHODOLOGY

      2 RESEARCH OBJECTIVES

      3 RESEARCH PROCESS

      4 SCOPE & COVERAGE

      4.1 MARKET DEFINITION

      4.1.1 INCLUSIONS

      4.1.2 EXCLUSIONS

      4.1.3 MARKET ESTIMATION CAVEATS

      4.2 BASE YEAR

      4.3 SCOPE OF THE STUDY

      4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

      5 REPORT ASSUMPTIONS & CAVEATS

      5.1 KEY CAVEATS

      5.2 CURRENCY CONVERSION

      5.3 MARKET DERIVATION

      6 PREMIUM INSIGHTS

      6.1 MARKET OVERVIEW

      6.1.1 MARKET DYNAMICS

      6.1.2 MARKET SEGMENTATION

      6.1.3 VENDOR ANALYSIS

      7 MARKET AT A GLANCE

      8 INTRODUCTION

      8.1 OVERVIEW

      9 MARKET OPPORTUNITIES & TRENDS

      9.1 SMARTPHONE & ARTIFICIAL INTELLIGENCE INTEGRATION IN LATERAL FLOW IMMUNOASSAY

      9.2 NEW APPLICATIONS OF LFAS

      9.3 SURGE IN DEMAND FOR LFAS IN FOOD & BEVERAGE INDUSTRY

      10 MARKET GROWTH ENABLERS

      10.1 PREVALENCE OF CHRONIC & INFECTIOUS DISEASES

      10.2 ADOPTION OF HOME-BASED LFA DEVICES

      10.3 DEMAND FOR POC TESTING

      11 MARKET RESTRAINTS

      11.1 AVAILABILITY OF ALTERNATIVE TESTING APPROACHES

      11.2 INCONSISTENT RESULTS & LIMITATIONS OF LFA TESTS

      11.3 CHALLENGES IN RAW MATERIAL SOURCING & LFA DEVELOPMENT

      12 MARKET LANDSCAPE

      12.1 MARKET OVERVIEW

      12.2 MARKET SIZE & FORECAST

      12.2.1 INSIGHT BY GEOGRAPHY SEGMENTATION

      12.2.2 INSIGHT BY PRODUCT SEGMENTATION

      12.2.3 INSIGHT BY TECHNIQUE SEGMENTATION

      12.2.4 INSIGHT BY APPLICATION SEGMENTATION

      12.2.5 INSIGHT BY END-USER SEGMENTATION

      12.3 FIVE FORCES ANALYSIS

      12.3.1 THREAT OF NEW ENTRANTS

      12.3.2 BARGAINING POWER OF SUPPLIERS

      12.3.3 BARGAINING POWER OF BUYERS

      12.3.4 THREAT OF SUBSTITUTES

      12.3.5 COMPETITIVE RIVALRY

      13 PRODUCT

      13.1 MARKET SNAPSHOT & GROWTH ENGINE

      13.2 MARKET OVERVIEW

      13.3 KITS & REAGENTS

      13.3.1 MARKET OVERVIEW

      13.3.2 MARKET SIZE & FORECAST

      13.3.3 MARKET BY GEOGRAPHY

      13.4 READERS

      13.4.1 MARKET OVERVIEW

      13.4.2 MARKET SIZE & FORECAST

      13.4.3 MARKET BY GEOGRAPHY

      14 APPLICATION

      14.1 MARKET SNAPSHOT & GROWTH ENGINE

      14.2 MARKET OVERVIEW

      14.3 CLINICAL DIAGNOSTICS

      14.3.1 MARKET OVERVIEW

      14.3.2 MARKET SIZE & FORECAST

      14.3.3 MARKET BY GEOGRAPHY

      14.4 FOOD SAFETY

      14.4.1 MARKET OVERVIEW

      14.4.2 MARKET SIZE & FORECAST

      14.4.3 MARKET BY GEOGRAPHY

      14.5 VETERINARY DIAGNOSTICS

      14.5.1 MARKET OVERVIEW

      14.5.2 MARKET SIZE & FORECAST

      14.5.3 MARKET BY GEOGRAPHY

      14.6 OTHERS

      14.6.1 MARKET OVERVIEW

      14.6.2 MARKET SIZE & FORECAST

      14.6.3 MARKET BY GEOGRAPHY

      15 TECHNIQUE

      15.1 MARKET SNAPSHOT & GROWTH ENGINE

      15.2 MARKET OVERVIEW

      15.3 SANDWICH ASSAYS

      15.3.1 MARKET OVERVIEW

      15.3.2 MARKET SIZE & FORECAST

      15.3.3 MARKET BY GEOGRAPHY

      15.4 COMPETITIVE ASSAYS

      15.4.1 MARKET OVERVIEW

      15.4.2 MARKET SIZE & FORECAST

      15.4.3 MARKET BY GEOGRAPHY

      16 END-USER

      16.1 MARKET SNAPSHOT & GROWTH ENGINE

      16.2 MARKET OVERVIEW

      16.3 HOSPITALS & CLINICS

      16.3.1 MARKET OVERVIEW

      16.3.2 MARKET SIZE & FORECAST

      16.3.3 MARKET BY GEOGRAPHY

      16.4 HOME HEALTHCARE

      16.4.1 MARKET OVERVIEW

      16.4.2 MARKET SIZE & FORECAST

      16.4.3 MARKET BY GEOGRAPHY

      16.5 DIAGNOSTIC LABORATORIES

      16.5.1 MARKET OVERVIEW

      16.5.2 MARKET SIZE & FORECAST

      16.5.3 MARKET BY GEOGRAPHY

      16.6 FOOD & BEVERAGE COMPANIES

      16.6.1 MARKET OVERVIEW

      16.6.2 MARKET SIZE & FORECAST

      16.6.3 MARKET BY GEOGRAPHY

      16.7 PHARMA & BIOTECH COMPANIES

      16.7.1 MARKET OVERVIEW

      16.7.2 MARKET SIZE & FORECAST

      16.7.3 MARKET BY GEOGRAPHY

      16.8 OTHERS

      16.8.1 MARKET OVERVIEW

      16.8.2 MARKET SIZE & FORECAST

      16.8.3 MARKET BY GEOGRAPHY

      17 GEOGRAPHY

      17.1 MARKET SNAPSHOT & GROWTH ENGINE

      17.2 GEOGRAPHIC OVERVIEW

      18 NORTH AMERICA

      18.1 MARKET OVERVIEW

      18.2 MARKET SIZE & FORECAST

      18.3 NORTH AMERICA: PRODUCT SEGMENTATION

      18.4 NORTH AMERICA: APPLICATION SEGMENTATION

      18.5 NORTH AMERICA: TECHNIQUE SEGMENTATION

      18.6 NORTH AMERICA: END-USER SEGMENTATION

      18.7 KEY COUNTRIES

      18.7.1 US: MARKET SIZE & FORECAST

      18.7.2 CANADA: MARKET SIZE & FORECAST

      19 EUROPE

      19.1 MARKET OVERVIEW

      19.2 MARKET SIZE & FORECAST

      19.3 EUROPE: PRODUCT SEGMENTATION

      19.4 EUROPE: APPLICATION SEGMENTATION

      19.5 EUROPE: TECHNIQUE SEGMENTATION

      19.6 EUROPE: END-USER SEGMENTATION

      19.7 KEY COUNTRIES

      19.7.1 UK: MARKET SIZE & FORECAST

      19.7.2 FRANCE: MARKET SIZE & FORECAST

      19.7.3 GERMANY: MARKET SIZE & FORECAST

      19.7.4 ITALY: MARKET SIZE & FORECAST

      19.7.5 RUSSIA: MARKET SIZE & FORECAST

      19.7.6 SPAIN: MARKET SIZE & FORECAST

      20 APAC

      20.1 MARKET OVERVIEW

      20.2 MARKET SIZE & FORECAST

      20.3 APAC: PRODUCT SEGMENTATION

      20.4 APAC: APPLICATION SEGMENTATION

      20.5 APAC: TECHNIQUE SEGMENTATION

      20.6 APAC: END-USER SEGMENTATION

      20.7 KEY COUNTRIES

      20.7.1 INDIA: MARKET SIZE & FORECAST

      20.7.2 CHINA: MARKET SIZE & FORECAST

      20.7.3 JAPAN: MARKET SIZE & FORECAST

      20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

      20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

      20.7.6 PHILIPPINES: MARKET SIZE & FORECAST

      21 LATIN AMERICA

      21.1 MARKET OVERVIEW

      21.2 MARKET SIZE & FORECAST

      21.3 LATIN AMERICA: PRODUCT SEGMENTATION

      21.4 LATIN AMERICA: APPLICATION SEGMENTATION

      21.5 LATIN AMERICA: TECHNIQUE SEGMENTATION

      21.6 LATIN AMERICA: END-USER SEGMENTATION

      21.7 KEY COUNTRIES

      21.7.1 BRAZIL: MARKET SIZE & FORECAST

      21.7.2 MEXICO: MARKET SIZE & FORECAST

      21.7.3 ARGENTINA: MARKET SIZE & FORECAST

      22 MIDDLE EAST & AFRICA

      22.1 MARKET OVERVIEW

      22.2 MARKET SIZE & FORECAST

      22.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

      22.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

      22.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION

      22.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

      22.7 KEY COUNTRIES

      22.7.1 TURKEY: MARKET SIZE & FORECAST

      22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

      22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

      23 COMPETITIVE LANDSCAPE

      23.1 COMPETITION OVERVIEW

      23.2 MARKET SHARE ANALYSIS

      24 KEY COMPANY PROFILES

      24.1 ABBOTT

      24.1.1 BUSINESS OVERVIEW

      24.1.2 PRODUCT OFFERINGS

      24.1.3 KEY STRATEGIES

      24.1.4 KEY STRENGTHS

      24.1.5 KEY OPPORTUNITIES

      24.2 F. HOFFMANN-LA ROCHE

      24.3 SIEMENS HEALTHINEERS

      24.4 THERMO FISHER SCIENTIFIC

      24.5 QUIDEL

      25 OTHER PROMINENT VENDORS

      25.1 ABAXIS

      25.1.1 BUSINESS OVERVIEW

      25.1.2 PRODUCT OFFERINGS

      25.2 ABINGDON HEALTH

      25.3 ACCESS BIO

      25.4 ARBOR VITA

      25.5 ASSURE TECH

      25.6 ATOMO DIAGNOSTICS

      25.7 ACCUBIOTECH

      25.8 BD

      25.9 BIOMÉRIEUX

      25.1 BIOLYTICAL LABORATORIES

      25.11 BIO-RAD LABORATORIES

      25.12 BIOSYNEX

      25.13 CUPID

      25.14 DIALAB

      25.15 HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH

      25.16 INTEC

      25.17 J. MITRA & CO. PVT.LTD.

      25.18 KHB

      25.19 MERIL LIFE SCIENCES

      25.20 MERCK KGAA

      25.21 MP BIOMEDICALS

      25.22 MEDSOURCE OZONE BIOMEDICALS

      25.23 NANJING SYNTHGENE MEDICAL TECHNOLOGY

      25.24 ORASURE TECHNOLOGIES

      25.25 PERKINELMER

      25.26 PREMIER MEDICAL

      25.27 QIAGEN

      25.28 REGA BIOTECHNOLOGY

      25.29 SD BIOSENSOR

      25.30 TÜRKLAB A.S.

      25.31 TRINITY BIOTECH

      25.32 WONDFO

      26 REPORT SUMMARY

      26.1 KEY TAKEAWAYS

      26.2 STRATEGIC RECOMMENDATIONS

      27 QUANTITATIVE SUMMARY

      27.1 MARKET BY PRODUCT

      27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION

      27.1.2 EUROPE: PRODUCT SEGMENTATION

      27.1.3 APAC: PRODUCT SEGMENTATION

      27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

      27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

      27.2 MARKET BY TECHNIQUE

      27.2.1 NORTH AMERICA: TECHNIQUE SEGMENTATION

      27.2.2 EUROPE: TECHNIQUE SEGMENTATION

      27.2.3 APAC: TECHNIQUE SEGMENTATION

      27.2.4 LATIN AMERICA: TECHNIQUE SEGMENTATION

      27.2.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION

      27.3 MARKET BY APPLICATION

      27.3.1 NORTH AMERICA: APPLICATION SEGMENTATION

      27.3.2 EUROPE: APPLICATION SEGMENTATION

      27.3.3 APAC: APPLICATION SEGMENTATION

      27.3.4 LATIN AMERICA: APPLICATION SEGMENTATION

      27.3.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

      27.4 MARKET BY END-USER

      27.4.1 NORTH AMERICA: END-USER SEGMENTATION

      27.4.2 EUROPE: END-USER SEGMENTATION

      27.4.3 APAC: END-USER SEGMENTATION

      27.4.4 LATIN AMERICA: END-USER SEGMENTATION

      27.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

      27.5 MARKET BY GEOGRAPHY

      27.5.1 KITS & REAGENTS: GEOGRAPHY SEGMENTATION

      27.5.2 READERS: GEOGRAPHY SEGMENTATION

      27.5.3 CLINICAL DIAGNOSTICS: GEOGRAPHY SEGMENTATION

      27.5.4 FOOD SAFETY: GEOGRAPHY SEGMENTATION

      27.5.5 VETERINARY DIAGNOSTICS: GEOGRAPHY SEGMENTATION

      27.5.6 OTHERS: GEOGRAPHY SEGMENTATION

      27.5.7 SANDWICH ASSAYS: GEOGRAPHY SEGMENTATION

      27.5.8 COMPETITIVE ASSAYS: GEOGRAPHY SEGMENTATION

      27.5.9 HOSPITALS & CLINICS: GEOGRAPHY SEGMENTATION

      27.5.10 HOME HEALTHCARE: GEOGRAPHY SEGMENTATION

      27.5.11 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION

      27.5.12 FOOD & BEVERAGE COMPANIES: GEOGRAPHY SEGMENTATION

      27.5.13 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION

      27.5.14 OTHERS: GEOGRAPHY SEGMENTATION

      28 APPENDIX

      28.1 ABBREVIATIONS

      About Us:   

      Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.  

      We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.  

      Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.  

      Click Here to Contact Us  

      Call: +1-312-235-2040  

                +1 302 469 0707  

      Mail: enquiry@arizton.com

      Photo: https://mma.prnewswire.com/media/1989726/Lateral_Flow_Assays_Market.jpg
      Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

      Modal title

      Also from this source

      Recreational Boat Market Set to Nearly Reach $50 Billion by 2031, Key Innovations Driving Growth - Exclusive Insights by Arizton

      Recreational Boat Market Set to Nearly Reach $50 Billion by 2031, Key Innovations Driving Growth - Exclusive Insights by Arizton

      According to Arizton's latest analysis, the global recreational boat market size was valued at USD 37 billion in 2025 and is projected to reach USD...

      Southeast Asia Data Center Investment to Reach USD 35.08 Billion by 2031 | Malaysia, Indonesia, Thailand & Singapore - Arizton

      Southeast Asia Data Center Investment to Reach USD 35.08 Billion by 2031 | Malaysia, Indonesia, Thailand & Singapore - Arizton

      Arizton's latest report highlights the continued expansion of Southeast Asia's data center market, with investments projected to grow from $15.72...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.